1. Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy. (1st April 2016) Authors: Weiss, Laurence; Chevalier, Mathieu F.; Assoumou, Lambert; Paul, Jean-Louis; Alhenc-Gelas, Martine; Didier, Céline; Taibi, Saïd; Manea, Elena-Maria; Campa, Pauline; Girard, Pierre-Marie; Costagliola, Dominique Journal: Journal of acquired immune deficiency syndromes Issue: Volume 71:Number 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗